Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alain Brecx"'
Autor:
Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon Hyung Kim, Myron J. Levin, Lidia Oostvogels, Toufik Zahaf, Anne Schuind, Anthony L. Cunningham
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2628-2633 (2020)
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster in adults ≥50 years of age. Solicited adverse events (AEs) w
Externí odkaz:
https://doaj.org/article/a426b076a4c9441b8ceb65db156795c0
Autor:
Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres, Desmond Curran, Carine De Kesel, Jean-Philippe De Saegher, Arnaud M Didierlaurent, Edouard Y Ledent, Johann F Mols, Tomas Mrkvan, Marie Normand-Bayle, Lidia Oostvogels, Fernanda Tavares Da Silva, Ventzislav Vassilev, Carlota Vinals, Alain Brecx
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 7, Pp 619-634 (2018)
Introduction: GSK has developed a two-dose adjuvanted recombinant zoster vaccine (Shingrix, RZV) to protect people aged ≥50 years (50+) against herpes zoster (HZ) and its complications. RZV showed >90% efficacy against HZ, sustained over 4 years of
Externí odkaz:
https://doaj.org/article/1b760f751a8344c4b6a80c0fa43d527a
Autor:
Lidia Oostvogels, Caroline Hervé, Myron J. Levin, Anne Schuind, Valentine Wascotte, Alain Brecx, Anthony L. Cunningham, Toufik Zahaf, Christopher J.P. Clarke, Joon Hyung Kim, Romulo E Colindres
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster in adults ≥50 years of age. Solicited adverse events (AEs) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7884a4c9a0fb3ce9badbe318c2d4d1ac
https://pubmed.ncbi.nlm.nih.gov/32347767
https://pubmed.ncbi.nlm.nih.gov/32347767
Autor:
Joon Hyung Kim, Lidia Oostvogels, Anne Schuind, Alain Brecx, Caroline Hervé, Valentine Wascotte, Romulo E Colindres, Christopher J.P. Clarke, Anthony L. Cunningham, Myron J. Levin, Toufik Zahaf
Publikováno v:
Open Forum Infectious Diseases
Background In the pivotal clinical trials, ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229), the adjuvanted recombinant zoster vaccine (RZV) showed high efficacy against herpes zoster and postherpetic neuralgia. The incidence of reported solicited event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809d6b425b82abf6ae1f3d0a2bca5baf
http://europepmc.org/articles/PMC6810576
http://europepmc.org/articles/PMC6810576
Publikováno v:
Regulatory Peptides. 47:195-203
Somatostatin is an endogenous cyclic tetradecapeptide which can exert effects on a wide range of gastrointestinal functions, including gastric acid and pepsin secretion, gastric and small intestinal motility, splanchnic blood flow, pancreatic enzyme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937af72e4c9c9f864957fc9b2abd83ca
https://doi.org/10.1016/0167-0115(93)90424-7
https://doi.org/10.1016/0167-0115(93)90424-7